The phase 2b/3 clinical trial (NCT05683496) evaluated izokibep versus placebo in non-infectious, non-anterior uveitis.

III-21,” a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of bovhyaluronidase azoximer ...

Gilead Sciences, Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...

About CT-P41 Phase III Clinical Trial The Phase III study randomised 479 patients ... 101). The primary efficacy endpoint was met in terms of percent change from baseline in bone mineral density (BMD) ...

11 years ago today, China became the third nation to land a rover on the moon with their Chang'e-3 orbiter and rover. The soft ...